Pharma and healthcare mutual funds have delivered positive returns over the last 1 year, but performance has varied sharply across schemes. While some active funds have gained more than 25%, several others have posted much lower returns.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.